Explore the latest in hepatitis B, including recent advances in diagnosis and antiviral treatment, prevention of complications, and more.
This review summarizes current evidence regarding diagnosis and treatment of hepatitis D virus.
This cohort study explores differences in recurrence-free survival and overall survival associated with tenofovir disoproxil vs entecavir after liver resection with curative intent in patients with hepatocellular cancer (HCC) related to hepatitis B virus (HBV).
This cohort study investigates the association of hepatitis B virus infection and time to pregnancy in couples planning pregnancy and explores whether this association varies by gravidity, health status, or lifestyle.
This cohort study assesses the association of maternal hepatitis B virus (HBV) serostatus with pregnancy outcomes in women undergoing freeze-thaw embryo transfer (FET).
This cohort study examines the association of daily drainage volume and the incidence of complications, such as hyponatremia or acute kidney injury, in patients with cirrhosis and refractory ascites treated with devices.
This Viewpoint outlines the progress made toward eliminating hepatitis B and C but emphasizes the work that remains to prioritize diagnosis and treatment of populations disproportionately affected by viral hepatitis, including ensuring that there are systems in place to treat those infected and care for those at risk.
This Viewpoint describes new recommendations from the CDC regarding universal screening of adults for hepatitis B virus infection.
This cohort study explores the association of maternal preconception hepatitis B virus infection with congenital heart diseases in offspring.
This cross-sectional study evaluates treatment with prescription medications in jails and state prisons relative to noncorrectional settings in the US.
This cohort study examines treatment for chronic hepatitis B among a racially diverse group of individuals in North America.
This cohort study assesses the prevalence of meeting successive markers of quality care for individuals with rheumatoid arthritis and characteristics associated with meeting these markers.
This cohort study investigates the association of heavy alcohol intake, aldehyde dehydrogenase 2 gene (ALDH2) rs671 polymorphism, and hepatitis B virus infection with hepatocellular carcinoma development and mortality in patients with cirrhosis.
This cohort study examines the associations of nationwide hepatitis B vaccination and antiviral therapy programs implemented in Taiwan with the burden of end-stage liver disease by age, period, and cohort.
This meta-analysis reconstructs individual participant data from high-quality, propensity score–matched cohort studies and provides more accurate and precise estimates of hepatocellular carcinoma (HCC) risk among patients with chronic hepatitis B virus.
This cross-sectional study assesses characteristics of US decedents with hepatitis B–listed deaths during 2010 to 2019 and compares rates with 2000 to 2009.
A woman with a history of intravenous heroin use and chronic inactive hepatitis B virus infection had sudden onset of painless jaundice and malaise. Vital signs, mentation, and physical examination were normal except for scleral icterus; she reported no history of travel outside the US and no raw meat ingestion; aminotransferase and bilirubin levels were newly elevated, but she had no acute hepatitis A or C virus infection. What is the diagnosis and what would you do next?
This large prospective cohort study compares the rates of acute myocardial infarction between recipients of a 2-dose hepatitis B vaccine and recipients of a 3-dose hepatitis B vaccine.
This cross-sectional study of health claims from patients with private insurance examines trends in the cost of entecavir prescribed for chronic hepatitis B treatment.
Customize your JAMA Network experience by selecting one or more topics from the list below.